AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questions
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
AstraZeneca is expected to encounter challenges at an upcoming advisory committee meeting due to questions from the FDA. The nature of these questions is not specified, but they appear to pose an obstacle for the company. The outcome of the meeting is uncertain.